Takeda Pharmaceutical (TAK) Current Assets (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Current Assets of $191.4 million for Q2 2026, down 98.9% year-over-year from $17.4 billion in Q2 2025, and up 67.19% quarter-over-quarter from $114.5 million in Q1 2026.
Takeda Pharmaceutical (TAK) Current Assets (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Current Assets history runs 10 years deep, the most recent figure standing at $191.4 million for Q2 2026.
- In Q2 2026, Current Assets fell 98.9% year-over-year to $191.4 million; the TTM figure through Jun 2026 stood at $191.4 million (down 98.9% YoY), while the FY2026 annual figure was $119.3 million, down 99.28% from the prior year.
- Current Assets for Q2 2026 stood at $191.4 million, up from $114.5 million in the prior quarter.
- The five-year high for Current Assets was $19.7 billion in Q2 2022, with the low at $24.1 million in Q2 2024.
- The 5-year median for Current Assets is $114.5 million (2026), against an average of $3.3 billion.
- The sharpest annual moves came in 2023 and 2025: Current Assets plunged 99.46% in 2023, then surged 71826.69% in 2025.
- Takeda Pharmaceutical's Current Assets stood at $52.1 million in 2022, then jumped by 150.93% to $130.7 million in 2023, then surged by 236.25% to $439.3 million in 2024, then slumped by 79.88% to $88.4 million in 2025, then jumped by 116.58% to $191.4 million in 2026.
- Business Quant data shows TAK's Current Assets at $191.4 million in Q2 2026, $114.5 million in Q1 2026, and $88.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 191.42 Mn |
| Mar 31, 2026 | 114.49 Mn |
| Dec 31, 2025 | 88.38 Mn |
| Sep 30, 2025 | 87.09 Mn |
| Jun 30, 2025 | 17.37 Bn |
| Mar 31, 2025 | 16.53 Bn |
| Dec 31, 2024 | 439.33 Mn |
| Sep 30, 2024 | 396.25 Mn |
| Jun 30, 2024 | 24.15 Mn |
| Mar 31, 2024 | 63.00 Mn |
| Dec 31, 2023 | 130.66 Mn |
| Sep 30, 2023 | 42.29 Mn |
| Jun 30, 2023 | 107.05 Mn |
| Mar 31, 2023 | 115.18 Mn |
| Dec 31, 2022 | 52.07 Mn |
| Sep 30, 2022 | 42.90 Mn |
| Jun 30, 2022 | 19.71 Bn |
| Dec 31, 2021 | 177.73 Mn |
| Sep 30, 2021 | 182.75 Mn |
| Jun 30, 2021 | 184.48 Mn |